Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
12.22
-0.99 (-7.53%)
At close: Mar 18, 2026, 4:00 PM EDT
12.10
-0.12 (-0.98%)
After-hours: Mar 18, 2026, 4:10 PM EDT
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $456.25 million as of March 18, 2026. Its market cap has increased by 168.58% in one year.
Market Cap
456.25M
Enterprise Value
201.60M
1-Year Change
168.58%
Ranking
Category
Stock Price
$12.22
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has increased from $402.09M to $456.25M, an increase of 13.47%. That is a compound annual growth rate of 6.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 493.40M | 18.17% |
| Dec 31, 2025 | 417.53M | 10.56% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neumora Therapeutics | 501.27M |
| Upstream Bio | 498.78M |
| Prothena Corporation | 495.80M |
| Lyell Immunopharma | 495.28M |
| Verastem | 491.88M |
| Invivyd | 491.71M |
| Lexeo Therapeutics | 486.10M |
| Atea Pharmaceuticals | 486.00M |